Enhancing Sleep Duration: Effects on Children's Eating and Activity Behaviors-Renewal

January 3, 2024 updated by: Temple University
Enhancing children's sleep may be a novel approach for prevention of obesity and cardiovascular (CV) disturbance. Observational studies with children demonstrate that short sleep increases risk of obesity and other CV risk factors. Randomized controlled trials with children 8-11 years old demonstrate that enhancing sleep duration leads to positive changes in eating and activity behaviors and weight status, particularly for children who enhance their sleep the most. Enhancing sleep may be particularly important for racial minority children and those from lower socioeconomic backgrounds given their increased risk for short sleep, obesity and CV risk factors. In this study two active obesity preventive interventions will be evaluated: a) enhancing sleep alone (Optimize Sleep [OS]), and b) enhancing sleep along with eating and activity behaviors that have demonstrated efficacy for obesity prevention and are implicated in self-regulatory pathways related to sleep (i.e., energy dense snack foods and beverages, TV viewing, and physical activity) (OS-Plus). Two hundred four children 6-11 years old who are primarily African American/black, primarily from low socioeconomic backgrounds, and who sleep < 9.5 hours/night into a 12-month study will be enrolled. Children will be randomly assigned to either OS or OS-Plus. Over the 6-month treatment phase, all children will attend an 8-session treatment; monthly phone contacts will occur during maintenance (6-12 months). Primary aim is to determine the efficacy of OS-Plus relative to OS on change in body mass index z-score (BMIz) at end of treatment. Secondary aims will assess efficacy of OS-Plus relative to OS on additional cardiometabolic risk factors, eating and activity behaviors. Exploratory aims will assess maintenance of effects at 12 months.

Study Overview

Study Type

Interventional

Enrollment (Actual)

149

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19122-6091
        • Temple University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 11 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Caregiver-reported child age of 6-11 years
  2. < 9.5 Hours time-in-bed for sleep most days/week
  3. BMI for age and gender > 25th percentile (but no greater than 100% overweight)
  4. Understanding of and ability to complete protocol
  5. Self-reported caregiver age of 18 years and primary caregiver at bedtimes/wake times
  6. Likes food used in the eating regulation paradigms
  7. Willingness to be randomized to either treatment condition.

Exclusion Criteria:

  1. Diagnosable sleep disorder
  2. Medication use or diagnosis of medical or psychiatric condition that may impact sleep/weight status
  3. Current or planned treatment for weight control
  4. Allergies or dietary restrictions that would prevent consumption of foods used in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Optimize Sleep (OS)
Optimize Sleep will focus exclusively on enhancing sleep by using effective behavioral strategies. Specific strategies to be used include: goal setting and self-monitoring, positive bedtime routines, stimulus control/sleep hygiene strategies, problem-solving regarding challenges, and review of effective strategies for relapse prevention.
All children will receive 8 sessions during active treatment: two in-person weekly, three in-person biweekly, and 3 monthly sessions conducted by phone. All families will be asked to complete 3 "sleep challenges" (at weeks 8, 16, and 20). During maintenance, families will continue with monthly phone contact.
Active Comparator: Optimize Sleep-Plus (OS-Plus)
OS-Plus will focus on enhancing sleep and targeted eating (decreasing sugar-sweetened beverages and sweet and salty snack foods) and activity (increasing physical activity and decreasing TV viewing) behaviors. Specific strategies to be used include: goal setting and self-monitoring, positive bedtime routines, stimulus control/sleep hygiene strategies, problem-solving regarding challenges, and review of effective strategies for relapse prevention.
All children will receive 8 sessions during active treatment: two in-person weekly, three in-person biweekly, and 3 monthly sessions conducted by phone. All families will be asked to complete 3 "sleep challenges" (at weeks 8, 16, and 20). During maintenance, families will continue with monthly phone contact.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in BMIz
Time Frame: Change from baseline BMIz at 6 months
change in body mass index z-score (accounting for child age and sex)
Change from baseline BMIz at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body Composition
Time Frame: Change from baseline percent body fat at 6 months
change in body composition (% body fat) will be estimated by air displacement plethysmography (BOD POD®; Life Measurement Instruments, Concord, CA)
Change from baseline percent body fat at 6 months
Change in Waist Circumference
Time Frame: Change from baseline waist circumference at 6 months
Change in measured waist circumference
Change from baseline waist circumference at 6 months
Change in Insulin Resistance
Time Frame: Change from baseline HOMA-IR at 6 months
Change in the homeostatic model assessment of insulin resistance (HOMA-IR)
Change from baseline HOMA-IR at 6 months
Change in Blood Glucose Levels
Time Frame: Change from baseline blood glucose levels at 6 months
2-hour blood glucose levels measured within the context of an oral glucose tolerance test
Change from baseline blood glucose levels at 6 months
Change in Non-HDL cholesterol (non-HDL-C)
Time Frame: Change from baseline in Non-HDL-C at 6 months
Total cholesterol (TC) minus HDL-C, includes LDL-C, VLDL-C, and atherogenic apo-B containing lipoproteins
Change from baseline in Non-HDL-C at 6 months
Change in Insulin Sensitivity Index (ISI)
Time Frame: Change from baseline ISI at 6 months
Insulin Sensitivity Index measured within the context of an oral glucose tolerance test
Change from baseline ISI at 6 months
Change in Sleep Period
Time Frame: Change from baseline in the sleep period at 6 months
Wrist-worn actigraphy
Change from baseline in the sleep period at 6 months
Change in Caloric Intake
Time Frame: Change from baseline in caloric intake at 6 months
24-hr dietary recalls on two days used to estimate caloric intake
Change from baseline in caloric intake at 6 months
Change in Food Reinforcement
Time Frame: Change from baseline in food reinforcement at 6 months
Measured using a validated computer activity (Behavioral Choice Task), which assesses motivation for a food reward
Change from baseline in food reinforcement at 6 months
Change in Eating in the Absence of Hunger (EAH)
Time Frame: Change from baseline in EAH at 6 months
Food consumed within the context of the eating in the absence of hunger paradigm
Change from baseline in EAH at 6 months
Change in Percent Time spent in Moderate to Vigorous Physical Activity (MVPA)
Time Frame: Change from baseline in MVPA at 6 months
Waist-worn accelerometer
Change from baseline in MVPA at 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chantelle N Hart, PhD, Temple University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Actual)

January 31, 2023

Study Completion (Actual)

September 30, 2023

Study Registration Dates

First Submitted

March 31, 2017

First Submitted That Met QC Criteria

June 12, 2017

First Posted (Actual)

June 14, 2017

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 3, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • R01HL092910 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Optimize Sleep (OS)

3
Subscribe